Drug Approval | October 04, 2023
Strides receives USFDA approval for Icosapent Ethyl capsules
The product is bioequivalent and therapeutically equivalent to the RLD, Vascepa of Amarin
The product is bioequivalent and therapeutically equivalent to the RLD, Vascepa of Amarin
Balaxi Healthcare Ecuador S.A.S. has become a Wholly Owned Subsidiary of the company
The sale/transfer of the Company's API NonAntibiotic Business and API Antibiotic Business to Apitoria are complete
Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de México, S.A. de C.V. becoming a wholly-owned subsidiary of the company.
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
WINLEVI works differently from any other topical acne treatment
The first phase of the hospital with 225 beds built over 1.75 lakh square feet will be commissioned in the next 12 months
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD)
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
This production block consists of chemical synthesis reactions and clean rooms areas to produce final API
Subscribe To Our Newsletter & Stay Updated
